Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Escalation of Care”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableStudy completedNCT03395951
What this trial is testing

Mean Systemic Filling Pressure Continuous Diuretics Critical Care Patients

Who this might be right for
SepsisHeart FailureHeart Diseases+3 more
Catharina Ziekenhuis Eindhoven 18
Testing effectiveness (Phase 2)Study completedNCT02138955
What this trial is testing

A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer

Who this might be right for
Patients w/Advanced Cancer That Failed Std of Care Therapy
SignPath Pharma, Inc. 30
Early research (Phase 1)Active Not RecruitingNCT05236036
What this trial is testing

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Who this might be right for
AstrocytomaGlioblastomaGlioblastoma, IDH-Wildtype+2 more
Northwestern University 86
Early research (Phase 1)Study completedNCT04116710
What this trial is testing

HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumor
Heat Biologics 15
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Testing effectiveness (Phase 2)WithdrawnNCT02367690
What this trial is testing

Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients

Who this might be right for
Diabetic Foot Ulcers
Karyopharm Therapeutics Inc
Not applicableStudy completedNCT03274063
What this trial is testing

Gout Self-Monitoring Aiming to Reach Target

Who this might be right for
Gout
University of Edinburgh 60
Large-scale testing (Phase 3)Looking for participantsNCT05696093
What this trial is testing

Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit

Who this might be right for
Ventilator Associated Pneumonia
Assistance Publique - Hôpitaux de Paris 628
Not applicableNot Yet RecruitingNCT07829367
What this trial is testing

Dyadic STEP-SexPCare for Sexual Health in Chinese Prostate Cancer Survivors and Their Female Partners

Who this might be right for
Prostate Cancer PatientsSexual Dysfunctions
The University of Hong Kong 72
Not applicableStudy completedNCT04628000
What this trial is testing

Baseline Vitamin D Deficiency and COVID-19 Disease Severity

Who this might be right for
Vitamin D DeficiencyCovid19
Parkview Medical Center 50
Early research (Phase 1)UnknownNCT05083000
What this trial is testing

Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care

Who this might be right for
COVID-19 Respiratory Infection
National University Hospital, Singapore 24
Testing effectiveness (Phase 2)Study completedNCT03466073
What this trial is testing

A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP

Who this might be right for
Community-acquired Pneumonia
BioAegis Therapeutics Inc. 33
Early research (Phase 1)Study completedNCT04539470
What this trial is testing

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Graft-versus-host Disease
Genentech, Inc. 18
Early research (Phase 1)UnknownNCT03024827
What this trial is testing

Cannabidiol in Children With Refractory Epileptic Encephalopathy

Who this might be right for
Epileptic Encephalopathy
University of Saskatchewan 20
Post-approval studies (Phase 4)UnknownNCT00808496
What this trial is testing

The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis

Who this might be right for
Inflammatory Arthritis
McMaster University 186
Early research (Phase 1)Active Not RecruitingNCT06077500
What this trial is testing

DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma (SCLC)
Boehringer Ingelheim 46
Not applicableStudy completedNCT05419687
What this trial is testing

Violence Against Health Care Workers in Fragile Settings

Who this might be right for
Workplace Violence
Swiss Tropical & Public Health Institute 798
Early research (Phase 1)Active Not RecruitingNCT06132113
What this trial is testing

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Neoplasms
Boehringer Ingelheim 65
Testing effectiveness (Phase 2)Study completedNCT03371251
What this trial is testing

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

Who this might be right for
Systemic Lupus Erythematosus
Boston Pharmaceuticals 143
Testing effectiveness (Phase 2)Looking for participantsNCT07206056
What this trial is testing

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Who this might be right for
Progressive Metastatic Castrate Resistant Prostate Cancer
Novartis Pharmaceuticals 188
Next Page